腾药热敷联合宫炎康颗粒治疗慢性盆腔炎的临床观察  

Clinical Observation of Teng Medicine Hot Compress Combined with Gongyankang Granules in the Treatment of Chronic of Pelvic Inflammatory Disease

作　　者：薛小荣[1] 胡斌[1] 王惠川[1] 王宝玲[2] 李琼阁[1] 寿晓嫒 和心依[1] 

机构地区：[1]西安市第四医院药剂科,西安710004 [2]西安市第四医院妇科,西安710004

出　　处：《中国药房》2017年第26期3657-3659,共3页China Pharmacy

基　　金：陕西省社会发展科技攻关项目(No.2015SF231)

摘　　要：目的:探讨腾药热敷联合宫炎康颗粒治疗慢性盆腔炎的临床疗效及安全性。方法:选取2015年7月-2016年6月我院门诊收治的慢性盆腔炎患者141例,按照随机数字表法分为对照组(65例)和观察组(76例)。对照组患者口服宫炎康颗粒9 g,bid;观察组患者在对照组基础上加用腾药热敷下腹部30 min,至凉为止,每日1次。两组患者均从月经期结束后第3天开始用药,连续治疗20 d。比较两组患者治疗前后的中医证候评分及局部体征评分及临床疗效,并记录两组患者的不良反应及复发情况。结果:治疗前,两组患者中医证候评分及局部体征评分比较,差异均无统计学意义(P>0.05);治疗后,两组患者中医证候评分、局部体征评分均显著降低,且观察组显著低于对照组,差异均有统计学意义(P<0.05)。观察组患者临床总有效率为92.11%,显著高于对照组的70.77%;观察组患者复发率为2.99%,显著低于对照组的15.79%,差异均有统计学意义(P<0.05)。两组患者均未见明显不良反应发生。结论:腾药热敷联合宫炎康颗粒治疗慢性盆腔炎疗效显著,能明显改善患者中医症候和局部症状,降低复发率,且安全性较好。OBJECTIVE： To investigate clinical efficacy and safety of Teng medicine combined with Gongyankang granules in the treatment of chronic pelvic inflammatory disease （CPID）. METHODS ： A total of 141 CPID outpatients were selected from our hospital during Jul. 2015-Jun.2016, other patients were divided into control group （65 cases） and observation group （76 cases） ac- cording to random number table. Control group was given Gongyankang granules 9 g orally, bid; observation group additionally re- ceived Teng medicine hot compress on lower abdomen for 30 min until it was cool, once a day, on the basis of control group. Both groups began the medication since third day after the menstrual period, for consecutive 20 d. TCM syndrome, local sign scores and clinical efficacies were compared between 2 groups before and after treatment, and the occurrence of ADR and recur- rence were observed in 2 groups. RESULTS： Before treatment, there was no statistical significance＇in TCM syndrome scores or lo- cal sign scores between 2 groups （P〉0.05）. After treatment, TCM syndrome scores and local sign scores of 2 groups were de- creased significantly, and the observation group was significantly lower than the control group, with statistical significance （P〈 0.05）. Clinical total response of observation group were 92.11%, which were significantly higher than 70.77% of control group, rate recurrence rate of observation group were 2.99%, which were significantly under than 15.79% of control group,with statistical significance （P〈0.05）. No obvious ADR was found in 2 groups. CONCLUSIONS： Teng medicine hot compress combined with Gongyankang granules show significant efficacy for CPID, can improve TCM syndrome and local sign and reduce recurrence rate with good safety.

关 键 词：腾药 热敷 慢性盆腔炎 宫炎康颗粒 

分 类 号：R711.33[医药卫生—妇产科学]